Manipulation of MAP3K Signaling to Improve CAR-T Cell Therapy

Authors

Raul Caballero Montes, The University of Texas MD Anderson Cancer CenterFollow
Meidi Gu MD, PhD, The University of Texas MD Anderson Cancer Center
Xiaofei Zhou PhD, The University of Texas MD Anderson Cancer Center
Shao-Cong Sun PhD, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

MAP3K, MAP3KΔN, Chimeric Antigen Receptor (CAR) T cells, Adoptive T-cell Therapy (ACT), Antitumor immunity

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRIT-CURE Summer Undergraduate Program

Recommended Citation

Caballero Montes, Raul; Gu, Meidi MD, PhD; Zhou, Xiaofei PhD; and Sun, Shao-Cong PhD, "Manipulation of MAP3K Signaling to Improve CAR-T Cell Therapy" (2021). Summer Experience 2021. 161.
https://openworks.mdanderson.org/sumexp21/161